Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,363 | -11,496 | -6,052 | -23,714 | -16,857 |
| Depreciation Amortization | 217 | 145 | 72 | 149 | 79 |
| Accounts receivable | -2,980 | -900 | -138 | -1,545 | N/A |
| Accounts payable and accrued liabilities | 551 | 615 | 557 | 1,612 | 1,756 |
| Other Working Capital | -4,354 | -1,834 | -716 | 1,103 | 2,033 |
| Other Operating Activity | 7,646 | 3,947 | 700 | 4,337 | 1,733 |
| Operating Cash Flow | $-12,283 | $-9,523 | $-5,577 | $-18,058 | $-11,256 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 24,935 | 25,000 |
| Debt Repayment | N/A | N/A | N/A | -5,000 | -5,000 |
| Common Stock Issued | 969 | 754 | 213 | 928 | 249 |
| Other Financing Activity | -61 | -47 | -20 | -131 | -341 |
| Financing Cash Flow | $908 | $707 | $193 | $20,732 | $19,908 |
| Beginning Cash Position | 23,774 | 23,774 | 23,774 | 21,100 | 21,100 |
| End Cash Position | 12,399 | 14,958 | 18,390 | 23,774 | 29,752 |
| Net Cash Flow | $-11,375 | $-8,816 | $-5,384 | $2,674 | $8,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,283 | -9,523 | -5,577 | -18,058 | -11,256 |
| Free Cash Flow | -12,283 | -9,523 | -5,577 | -18,058 | -11,256 |